Hexaware Strengthens Data Capabilities with Acquisition of Softcrylic Know More
Our client, a leading pharmaceutical CSO (Contract Sales Organization) and a drug commercialization partner understands the crucial role of data analytics in pharmaceuticals in driving informed decision-making and strategic advancements. They have been offering innovative healthcare solutions and vital insights to manage challenges in pharma commercialization. With expertise spanning clinical and medical outsourced teams, remote and field sales solutions, capabilities development, recruiting, operations, and consulting, they help their customers navigate the road from new drug development to new therapy success and patient care, pushing the boundaries of commercialization strategies to enhance patient’s lives.
Despite their prominence in the pharmaceutical sector, our client faced significant challenges:
Fragmented Data Ecosystem: The absence of a centralized data warehouse hindered integrated insights across sales, marketing, and other vital functions, impairing strategic decision-making.
Inconsistent Analysis Capability: The lack of cohesive data setups led to varying analytical capabilities, thereby weakening the ability of sales reps, MSLs, account managers, field operations teams, and CSRs to make informed business decisions.
Data Quality Concerns: Sub-optimal data quality from disparate systems compromised the accuracy and reliability of analysis, posing significant challenges to ensuring contract compliance and optimizing sales performance.
Ad-hoc Reporting Dependency: Relying on third-party vendors for ad-hoc reporting introduced inefficiencies and delays, hindering agility and responsiveness in decision-making workflows.
As a strategic partner, Hexaware embarked on a journey to develop an integrated data hub with advanced analytics capabilities. We began with a strategic assessment of the client’s current ecosystem and proceeded to craft a future state architecture in Microsoft Azure, leveraging native Azure services. Here’s how we transformed their operations:
Data Integration and Transformation:
Centralized Data Warehouse Construction:
Business-centric Reporting and Analytics:
Our solution not only enhanced the analytical capabilities of the company but also facilitated a transition from disjointed siloed systems to a centralized commercial data repository tailored for the pharmaceutical industry. This aligns with the long-term strategic goals of our client, encompassing the following key objectives:
Through business intelligence and data analytics services, Hexaware embarked on the transformative journey of a leading pharmaceutical CSO to revolutionize its data management and analytics capabilities. From overcoming data fragmentation to establishing a centralized repository, Hexaware’s solutions aligned seamlessly with the client’s strategic objectives. By empowering stakeholders with enriched insights, ensuring data integrity, and fostering collaboration, the company today strides confidently into the future of pharmaceutical excellence.
Fill out the form below to gain instant access to our exclusive content.
Every outcome starts with a conversation